Literature DB >> 12865588

Miltefosine: great expectations against visceral leishmaniasis.

B More1, H Bhatt, V Kukreja, S S Ainapure.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12865588     DOI： 10.4103/0022-3859.911

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India.

Authors:  Shyam Sundar; Prabhat K Sinha; Susan A Dixon; Renata Buckley; Ann K Miller; Khadeeja Mohamed; Mahir Al-Banna
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Miltefosine: First Oral Drug for Treatment of Visceral Leishmaniasis.

Authors:  V K Agrawal; Zile Singh
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.

Authors:  Maha M Eissa; Riham M El-Moslemany; Alyaa A Ramadan; Eglal I Amer; Mervat Z El-Azzouni; Labiba K El-Khordagui
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.